Total Funding
51
50
Total FundingGrant raised
Growth Score
-10 pts
Heat Score
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
24009
ImmunoVec develops gene therapy treatments to cure terminal genetic diseases of the immune system.
William Woodward: Co-Founder and CEO- Ryan Wong: Co-Founder and Executive Vice President of Research and Development
About the Company
ImmunoVec develops gene therapy treatments to cure terminal genetic diseases of the immune system. Its gene therapy is intended for hematopoietic diseases.
Women Founded
